Janssen

News

Mundipharma to distribute J&J diabetes drugs in Europe

European pharma group Mundipharma has struck a deal with Janssen for two primary care diabetes drugs, Invokana and Vokanamet, in selected European countries.

News

Janssen and Bavarian Nordic sign $836m deal on Hep B and HIV...

Janssen has signed a new deal with Bavarian Nordic worth up to $836 million to develop target vaccines for hepatitis B and HIV.

News

HIV vaccine shows ‘encouraging’ early results

Janssen has unveiled what it calls ‘encouraging’ early results of its vaccine to prevent infection by HIV.

Views & Analysis

London, UK - January 8, 2015: City of London panorama includes high street with office and governments buildings

Europe has untapped medical innovation – but needs high spee...

The head of Johnson & Johnson (J&J) Innovation in Europe says the region is ripe for more life sciences investment, but warns that the UK, its biotech leader, could miss out withou

Views & Analysis